Skip to main navigation
Skip to search
Skip to main content
Fujita Health University Home
English
日本語
Search content at Fujita Health University
Home
Profiles
Research units
Research output
Prizes
Clinical Usefulness of Serum CYFRA21-1 in Primary Lung Cancer
Takahiko Horiguchi
, Soichi Tachikawa
, Hiroshi Hosoda
Respiratory Medicine & Clinical Allergy
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clinical Usefulness of Serum CYFRA21-1 in Primary Lung Cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Usefulness
100%
Primary Lung Cancer
100%
CYFRA 21-1
100%
Positive Rate
75%
Squamous Cell Carcinoma (SqCC)
50%
Pulmonary Disease
50%
Lung Cancer
25%
Healthy Volunteers
25%
Adenocarcinoma
25%
Immunohistochemical Staining
25%
Tumor Marker
25%
Strongly Positive
25%
False Positive Rate
25%
Serum Tumor Markers
25%
New Tumor Markers
25%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Tumor Marker
60%
Squamous Cell Carcinoma
40%
Lung Disease
40%
Cytokeratin 19 Fragment
40%
Normal Human
20%
Adenocarcinoma
20%
Carcinoembryonic Antigen
20%
Biochemistry, Genetics and Molecular Biology
Tumor Marker
100%
Normal Human
33%
Staining
33%
Carcinoembryonic Antigen
33%
Keratin 19
33%
Spin Echo
33%